JACOB J. SILVERMAN, M.D., F.A.C.P.; THEODORE J. TALBOT, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
Diffuse interstitial fibrosis of the lungs, first described in 1944 by Hamman and Rich,1 is a rare condition the diagnosis of which is established after death and only after careful microscopic studies.1-12 It is the purpose of this report to present a case of diffuse interstitial fibrosis of the lungs that was correctly diagnosed before death by means of cardiac catheterization and lung biopsy studies. The report is of additional interest because of several unusual features. First, the patient demonstrated early in the course of the illness a hypermetabolic state that was erroneously interpreted and treated as hyperthyroidism. Later he
SILVERMAN JJ, TALBOT TJ. DIFFUSE INTERSTITIAL PULMONARY FIBROSIS CAMOUFLAGED BY HYPERMETABOLISM AND CARDIAC FAILURE: ANTEMORTEM DIAGNOSIS WITH BIOPSY AND CATHETERIZATION STUDIES*. Ann Intern Med. 1953;38:1326–1338. doi: https://doi.org/10.7326/0003-4819-38-6-1326
Download citation file:
Published: Ann Intern Med. 1953;38(6):1326-1338.
Cardiology, Heart Failure, Interstitial Lung Disease, Pulmonary/Critical Care.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use